Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Alzheimer's Disease”

317 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 317 results

Testing effectiveness (Phase 2)Study completedNCT00742417
What this trial is testing

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 42
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Large-scale testing (Phase 3)Ended earlyNCT05026177
What this trial is testing

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,125
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Not applicableStudy completedNCT05527288
What this trial is testing

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Who this might be right for
Alzheimer DiseaseDementiaBrain Diseases+6 more
Sinotau Pharmaceutical Group 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178678
What this trial is testing

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild Alzheimer's DiseaseModerate Alzheimer's Disease
University of Saskatchewan 90
Large-scale testing (Phase 3)Ended earlyNCT00550420
What this trial is testing

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 331
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)Study completedNCT01073228
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 409
Post-approval studies (Phase 4)Study completedNCT02703636
What this trial is testing

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Testing effectiveness (Phase 2)Ended earlyNCT00606476
What this trial is testing

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 194
Large-scale testing (Phase 3)Ended earlyNCT05575076
What this trial is testing

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)Study completedNCT02947893
What this trial is testing

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Georgetown University 37
Large-scale testing (Phase 3)UnknownNCT00088673
What this trial is testing

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Bellus Health Inc. - a GSK company 950
Large-scale testing (Phase 3)Ended earlyNCT02248116
What this trial is testing

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 198
Large-scale testing (Phase 3)Ended earlyNCT01739348
What this trial is testing

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 2,211
Testing effectiveness (Phase 2)Study completedNCT00224497
What this trial is testing

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 380
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Next Page